Val Gene Romberg

Wuhan Zhongyuan Ruide Biological Products Co., Ltd. engages in the research and development, manufacture, and sale of biological products and blood products. The company was founded on on June 11, 2010 and is headquartered in Wuhan, China.

Part of CSL Ltd., CSL Behring Holdings Ltd. provides investment services. The company is based in Haywards Heath, UK. CSL Behring Holdings was founded in 1995.

Kedrion Biopharma, Inc. operates as an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing diseases, disorders and conditions such as hemophilia, primary immune system deficiencies and Rh-sensitization. Its services include Italian partnership, contract manufacturing, technology transfer, and biological safety center. The company was founded in 2011 and is headquartered in Fort Lee, NJ.

Kedrion SpA is a holding company, which engages in the production and distribution of plasma-derived therapeutic products for the treatment of hemophilia and immune system deficiencies. It offers standard intravenous immunoglobulin, human albumin solution, human rabies immunoglobulin, prothrombin complex concentrate, and fibrin sealant. Its products include Kedrab, Gammaked, Uman Complex, Kolfib, and Uman Albumin. The company was founded by Guelfo Marcucci in 2001 and is headquartered in Barga, Italy.

Part of CSL Ltd., CSL Behring Holdings GmbH is a German company that functions as an investment holding company. The company is based in Marburg, Germany. The CEOs are Val Gene Romberg, Berthold Suesser. The company was founded in 2014.

CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA.